Showing
1 - 4
results of
4
for search '
Conti, R.
'
Skip to content
Home
High Impact Articles
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
Jawi Collection
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Conti, R.
Showing
1 - 4
results of
4
for search '
Conti, R.
'
, query time: 0.06s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
A Thermo-Hydraulic Tool for Automatic Virtual Hazop Evaluation
by
Pugi L.
,
Conti
R
.
,
Rindi A.
,
Rossin S.
Published 2014-12-01
Get full text
Article
2
The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia
by
Becker, R.V
,
Conti
,
R
.M
,
Padula, W.V
,
Salamone, S.
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
3
Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists
by
Chua, K.-P
,
Ciaccio, C.
,
Conti
,
R
.
,
Pelczar, A.
,
Volerman, A.
Published 2022
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
4
Sub-millisecond optogenetic control of neuronal firing with two-photon holographic photoactivation of Chronos
by
Ronzitti, E.
,
Conti
,
R
.
,
Zampini, V.
,
Tanese, D.
,
Foust, A.J
,
Papagiakoumou, E.
,
Emiliani, V.
,
Klapoetke, Nathan Cao
,
Boyden, Edward
Published 2018
Call Number:
Loading...
Located:
Loading...
Get fulltext
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
Albuterol
Article
Cost-Benefit Analysis
Drug Monitoring
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Low-value care
Medicaid
Preferred drug list
Prescription Drugs
Quality-Adjusted Life Years
United States
adult
animal experiment
animal model
chronic myeloid leukemia
clinical outcome
consumer price index
cost
cost benefit analysis
cost control
cost effectiveness analysis
dasatinib
drug cost
drug efficacy
drug monitoring
drug substitution
drug withdrawal
economics
female
Loading...